Design Therapeutics, Inc.DSGNNASDAQ
Loading
Net Income Growth Under PressureDecelerating
Percentile Rank83
3Y CAGR+42.0%
Year-over-Year Change
Year-over-year net income growth rate
3Y CAGR
+42.0%/yr
Quarterly compound
Percentile
P83
Within normal range
vs 3Y Ago
2.9x
Strong expansion
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | 5.88% |
| Q3 2025 | 10.93% |
| Q2 2025 | -7.72% |
| Q1 2025 | -29.77% |
| Q4 2024 | -4.69% |
| Q3 2024 | -10.57% |
| Q2 2024 | -6.20% |
| Q1 2024 | 6.22% |
| Q4 2023 | 25.00% |
| Q3 2023 | 20.81% |
| Q2 2023 | -3.33% |
| Q1 2023 | -11.27% |
| Q4 2022 | 2.06% |
| Q3 2022 | -18.03% |
| Q2 2022 | -13.07% |
| Q1 2022 | -19.88% |
| Q4 2021 | 2.24% |
| Q3 2021 | -48.22% |
| Q2 2021 | -38.48% |
| Q1 2021 | -43.04% |
| Q4 2020 | -66.16% |
| Q3 2020 | -60.89% |
| Q2 2020 | -117.50% |
| Q1 2020 | 0.00% |